Իսրայել - անգլերեն - Ministry of Health

padagis israel agencies ltd, israel - granisetron as hydrochloride - tablets - granisetron as hydrochloride 1 mg - granisetron - granisetron - prevention of nausea and vomiting induced by cytostatic therapy.

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - palonosetron - raztopina za injiciranje - palonosetron 250 µg / 1 viala - palonosetron

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fresenius kabi deutschland gmbh - palonosetron - raztopina za injiciranje - palonosetron 250 µg / 1 viala - palonosetron

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - palonosetron - raztopina za injiciranje - palonosetron 250 µg / 1 viala - palonosetron

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - ondansetron - filmsko obložena tableta - ondansetron 4 mg / 1 tableta - ondansetron

Սլովենիա - սլովեներեն - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ebewe pharma - ondansetron - filmsko obložena tableta - ondansetron 8 mg / 1 tableta - ondansetron

Բելգիա - հոլանդերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - ondansetronhydrochloride 5 mg - eq. ondansetron 4 mg - filmomhulde tablet - 4 mg - ondansetronhydrochloride 5 mg - ondansetron

Բելգիա - հոլանդերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - ondansetronhydrochloride 10 mg - eq. ondansetron 8 mg - filmomhulde tablet - 8 mg - ondansetronhydrochloride 10 mg - ondansetron

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

dr.reddy's laboratories limited - palonosetron hydrochloride (unii: 23310d4i19) (palonosetron - unii:5d06587d6r) - palonosetron 0.05 mg in 1 ml - palonosetron hydrochloride injection is indicated in adults for prevention of: - acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (mec). - acute nausea and vomiting associated with initial and repeat courses highly emetogenic cancer chemotherapy (hec). - postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. efficacy beyond 24 hours has not been demonstrated. as with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and vomiting must be avoided during the postoperative period, palonosetron hydrochloride is recommended even where the incidence of postoperative nausea and/or vomiting is low. palonosetron hydrochloride injection is indicated in pediatric patients 1 month to less than 17 years of age for prevention of: - acute nausea and vomiting associated with initial and repea

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

sandoz inc - palonosetron hydrochloride (unii: 23310d4i19) (palonosetron - unii:5d06587d6r) - palonosetron 0.25 mg in 5 ml - palonosetron injection is indicated in adults for prevention of: - acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (mec). - acute nausea and vomiting associated with initial and repeat courses highly emetogenic cancer chemotherapy (hec). - postoperative nausea and vomiting (ponv) for up to 24 hours following surgery. efficacy beyond 24 hours has not been demonstrated. as with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and vomiting must be avoided during the postoperative period, palonosetron is recommended even where the incidence of postoperative nausea and/or vomiting is low. palonosetron hcl injection is indicated in pediatric patients 1 month to less than 17 years of age for prevention of: • acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemoth